文献速递传染病防控与疫情报告卫生政策与健康促进

荷德边境42家医院耐甲氧西林金黄色葡萄球菌流行病学变化(2012—2016):search-and-follow策略结果

Changing epidemiology of meticillin-resistant Staphylococcus aureus in 42 hospitals in the Dutch-German border region, 2012 to 2016: results of the search-and-follow-policy.
PubMed 文献 · Euro Surveill · 2019-01-01

该研究基于荷德边境网络42家医院(荷兰8家、德国34家)2012—2016年监测数据,描述MRSA定植/感染及菌血症率趋势。德国医院鼻咽MRSA筛查率、MRSA发病率、院内MRSA incidence-density及血流分离率均显著高于荷兰医院,德国院内MRSA incidence-density在研究期间显著下降。结论认为持续感染预防控制努力使德国医院MRSA减少,但医疗体系等本地因素也可能影响MRSA流行病学。

要点

  • 德国医院鼻咽MRSA筛查率为42.3/100住院患者,荷兰为3.0/100,德国高14倍(p<0.0001)。
  • 德国医院MRSA发病率为1.04/100住院患者,荷兰为0.14/100,德国高逾7倍(p<0.0001)。
  • 德国医院院内MRSA incidence-density为0.09/1000患者日,荷兰为0.03/1000患者日,德国显著更高(p=0.0002)且研究期间显著下降(p=0.0184)。

核心结论

  • 持续感染预防控制努力使德国边境医院MRSA减少,但医疗体系等本地因素也可能影响MRSA流行病学。

研究设计与样本

  • 荷德边境网络EurSafety Health-net内42家医院(荷兰8家、德国34家)2012—2016年监测数据分析,年均约62万住院患者,其中68.0%在德国。

主要发现

  • 德国医院鼻咽MRSA筛查率为42.3/100住院患者,荷兰为3.0/100,德国高14倍(p<0.0001)。
  • 德国医院MRSA发病率为1.04/100住院患者,荷兰为0.14/100,德国高逾7倍(p<0.0001)。
  • 德国医院院内MRSA incidence-density为0.09/1000患者日,荷兰为0.03/1000患者日(p=0.0002),德国研究期间显著下降(p=0.0184)。
  • 德国医院每10万患者日血流MRSA分离率为1.55,荷兰为0.26,德国高近6倍(p=0.0041)。
  • 德国医院患者住院时间中位数为6.8天,荷兰为4.9天(p<0.0001),且德国医院服务区居民住院更频繁。

关键数值与推荐

  • 两国MRSA病例处理措施相似,但定义MRSA风险患者的标准不同。

临床怎么用

  • 跨境医院网络应关注筛查策略与风险患者定义差异对MRSA监测指标可比性的影响。
  • 德国医院较高的筛查率与MRSA发病率并存,提示需结合本地医疗体系因素解读监测数据。

局限性

  • 原文摘要未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IntroductionMeticillin-resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-associated infections.AimWe describe MRSA colonisation/infection and bacteraemia rate trends in Dutch-German border region hospitals (NL-DE-BRH) in 2012-16.MethodsAll 42 NL-DE BRH (8 NL-BRH, 34 DE-BRH) within the cross-border network EurSafety Health-net provided surveillance data (on average ca 620,000 annual hospital admissions, of these 68.0% in Germany). Guidelines defining risk for MRSA colonisation/infection were reviewed. MRSA-related parameters and healthcare utilisation indicators were derived. Medians over the study period were compared between NL- and DE-BRH.ResultsMeasures for MRSA cases were similar in both countries, however defining patients at risk for MRSA differed. The rate of nasopharyngeal MRSA screening swabs was 14 times higher in DE-BRH than in NL-BRH (42.3 vs 3.0/100 inpatients; p < 0.0001). The MRSA incidence was over seven times higher in DE-BRH than in NL-BRH (1.04 vs 0.14/100 inpatients; p < 0.0001). The nosocomial MRSA incidence-density was higher in DE-BRH than in NL-BRH (0.09 vs 0.03/1,000 patient days; p = 0.0002) and decreased significantly in DE-BRH (p = 0.0184) during the study. The rate of MRSA isolates from blood per 100,000 patient days was almost six times higher in DE-BRH than in NL-BRH (1.55 vs 0.26; p = 0.0041). The patients had longer hospital stays in DE-BRH than in NL-BRH (6.8 vs 4.9; p < 0.0001). DE-BRH catchment area inhabitants appeared to be more frequently hospitalised than their Dutch counterparts.ConclusionsOngoing IPC efforts allowed MRSA reduction in DE-BRH. Besides IPC, other local factors, including healthcare systems, could influence MRSA epidemiology.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Jurke A, Daniels-Haardt I, Silvis W, et al. Changing epidemiology of meticillin-resistant Staphylococcus aureus in 42 hospitals in the Dutch-German border region, 2012 to 2016: results of the search-and-follow-policy. Euro Surveill. 2019. PMID: 30994105. doi:10.2807/1560-7917.ES.2019.24.15.1800244

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。